{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:29:42Z","timestamp":1791253782182,"version":"4.1.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2012,11,19]],"date-time":"2012-11-19T00:00:00Z","timestamp":1353283200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0048499","type":"journal-article","created":{"date-parts":[[2012,11,19]],"date-time":"2012-11-19T22:15:54Z","timestamp":1353363354000},"page":"e48499","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Circulating Levels of Dimethylarginines, Chronic Kidney Disease and Long-Term Clinical Outcome in Non-ST-Elevation Myocardial Infarction"],"prefix":"10.1371","volume":"7","author":[{"given":"Viviana","family":"Cavalca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Veglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Squellerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"De Metrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Porro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Moltrasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Tremoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Marenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,11,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/01.HYP.0000102971.85504.7c","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention","volume":"42","author":"MJ Sarnak","year":"2003","journal-title":"Hypertension"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risk of death, cardiovascular events, and hospitalization","volume":"351","author":"AS Go","year":"2004","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJM199809173391203","article-title":"Poor-long-term survival after acute myocardial infarction among patients on long-term dialysis","volume":"339","author":"CA Herzog","year":"1998","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.7326\/0003-4819-137-7-200210010-00007","article-title":"Acute myocardial infarction and renal dysfunction: a high-risk combination","volume":"137","author":"RS Wright","year":"2002","journal-title":"Ann Intern Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7326\/0003-4819-137-7-200210010-00006","article-title":"Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients","volume":"137","author":"MG Shlipak","year":"2002","journal-title":"Ann Intern Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/heart.89.9.1003","article-title":"Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE)","volume":"89","author":"JJ Santopinto","year":"2003","journal-title":"Heart"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.ehj.2004.08.016","article-title":"Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13307 patients in five TIMI trials","volume":"25","author":"CM Gibson","year":"2004","journal-title":"Eur Heart J"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/CIRCULATIONAHA.108.838169","article-title":"Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART)","volume":"120","author":"K Szummer","year":"2009","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/CIRCULATIONAHA.109.865352","article-title":"Acute Coronary Treatment and Intervention Outcomes Network registry. Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry","volume":"121","author":"CS Fox","year":"2010","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(01)07217-8","article-title":"Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study","volume":"358","author":"C Zoccali","year":"2001","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1681\/ASN.2005010076","article-title":"Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach","volume":"16","author":"P Ravani","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1161\/01.CIR.98.18.1842","article-title":"Asymmetric dimethylarginine (ADMA): A novel risk factor for endothelial dysfunction\u2014Its role in hypercholesterolemia","volume":"98","author":"RH B\u00f6ger","year":"1998","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1464-5491.2007.02018.x","article-title":"Asymmetrical dimethylarginine is related to renal function, chronic inflammation and macroangiopathy in patients with type 2 diabetes and albuminuria","volume":"24","author":"K Krzyzanowska","year":"2007","journal-title":"Diabet Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2337\/dc07-1762","article-title":"Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy","volume":"31","author":"M Lajer","year":"2008","journal-title":"Diabetes Care"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1681\/ASN.2005101119","article-title":"Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease","volume":"17","author":"SM Bode-B\u00f6ger","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-8981(03)00338-3","article-title":"Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases","volume":"336","author":"C Fleck","year":"2003","journal-title":"Clin Chim Acta"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.freeradbiomed.2009.05.007","article-title":"Dimethylarginines in complicated type 1 diabetes: roles of insulin, glucose, and oxidative stress","volume":"47","author":"G Cighetti","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1093\/eurheartj\/ehn360","article-title":"Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure","volume":"29","author":"WH Wilson Tang","year":"2008","journal-title":"Eur Heart J"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0031-6997(25)06663-3","article-title":"Nitric oxide: physiology, pathophysiology and pharmacology","volume":"43","author":"S Moncada","year":"1991","journal-title":"Pharmacol Rev"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(87)91481-4","article-title":"Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium","volume":"2","author":"MW Radomski","year":"1987","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation","volume":"130","author":"AS Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"ref22","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ab.2006.03.010","article-title":"Analysis of asymmetric dimethylarginine in plasma by HPLC using a monolithic column","volume":"353","author":"S de Jong","year":"2006","journal-title":"Anal Biochem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/157340306775515371","article-title":"Management of acute coronary syndromes in patients with renal insufficiency","volume":"2","author":"G Marenzi","year":"2006","journal-title":"Current Cardiology Reviews"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1054\/clnu.2002.0613","article-title":"Asymmetric dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality","volume":"22","author":"RJ Nijveldt","year":"2003","journal-title":"Clin Nutr"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.2215\/CJN.08490910","article-title":"Asymmetric dimethylarginine and clinical outcomes in chronic kidney disease","volume":"6","author":"TM Lu","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.ehj.2003.08.013","article-title":"Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention","volume":"24","author":"TM Lu","year":"2003","journal-title":"Eur Heart J"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijcard.2011.06.120","article-title":"Plasma asymmetric dimethylarginine predicts death and major adverse cardiovascular events in individuals referred for coronary angiography","volume":"153","author":"TM Lu","year":"2011","journal-title":"Int J Cardiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1097\/01.CCM.0000277038.11630.71","article-title":"Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine predict adverse events in patients undergoing noncardiac surgery","volume":"35","author":"R Maas","year":"2007","journal-title":"Crit Care Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1161\/01.ATV.0000081742.92006.59","article-title":"Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase","volume":"23","author":"V Achan","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1161\/01.CIR.0000105764.22626.B1","article-title":"Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetric dimethylarginine in humans","volume":"109","author":"JT Kielstein","year":"2004","journal-title":"Circulation"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.amjcard.2004.11.023","article-title":"Plasma asymmetric dimethylarginine concentrations in newly diagnosed patients with acute myocardial infarction or unstable angina pectoris during two weeks of medical treatment","volume":"95","author":"SW Bae","year":"2005","journal-title":"Am J Cardiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/MCA.0b013e328323982f","article-title":"Relationship of baseline plasma ADMA levels to cardiovascular outcomes at 2 years in men with acute coronary syndrome referred for coronary angiography","volume":"20","author":"E Cavusoglu","year":"2009","journal-title":"Coron Artery Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.atherosclerosis.2008.12.024","article-title":"Asymmetric dimethylarginine induces tissue factor expression in monocytes via NF-kappaB-dependent pathway: Role in acute coronary syndromes","volume":"205","author":"DJ Jiang","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cca.2007.07.006","article-title":"Reference values for plasma concentrations of asymmetrical dimethylarginine (ADMA) and other arginine metabolites in men after validation of a chromatographic method","volume":"384","author":"A Meinitzer","year":"2007","journal-title":"Clin Chim Acta"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1093\/ndt\/gfl292","article-title":"Symmetric dimethylarginine (SDMA) as endogenous marker of renal function\u2014a meta-analysis","volume":"21","author":"JT Kielstein","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0140-6736(92)90865-Z","article-title":"Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure","volume":"339","author":"P Vallance","year":"1992","journal-title":"Lancet"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1006\/niox.1996.0106","article-title":"Interference of L-arginine analogues with L-arginine transport mediated by the y\u00fe carrier hCAT-2B","volume":"1","author":"EI Closs","year":"1997","journal-title":"Nitric Oxide"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/ki.1997.490","article-title":"Colocalization of demethylating enzymes and NOS and functional effects of methylarginines in rat kidney","volume":"52","author":"A Tojo","year":"1997","journal-title":"Kidney Int"},{"key":"ref40","first-page":"524","article-title":"NG, NG-dimethylarginine and NG, NG-dimethylarginine in renal insufficiency","volume":"439","author":"M Al Banchaabouchi","year":"2000","journal-title":"Pflugers Arch"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ki.1985.205","article-title":"Limitations of creatinine as a filtration marker in glomerulopathic patients","volume":"28","author":"O Shemesh","year":"1985","journal-title":"Kidney Int"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.2215\/CJN.01720211","article-title":"Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease","volume":"6","author":"E Schepers","year":"2011","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0048499","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T05:57:55Z","timestamp":1745215075000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0048499"}},"subtitle":[],"editor":[{"given":"Claudio","family":"Moretti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,11,19]]},"references-count":42,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2012,11,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0048499","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,19]]}}}